New combo therapy aims to calm rosacea flare-ups
NCT ID NCT07343635
First seen Jan 16, 2026 · Last updated May 23, 2026 · Updated 22 times
Summary
This study is testing whether a special cream followed by yellow light therapy, plus two oral medications (tofacitinib and doxycycline), can safely reduce redness and bumps in adults with mild to moderate rosacea. About 186 Chinese adults aged 18 to 70 will take part. The goal is to see if the treatment clears the skin better than standard care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ERYTHEMATOTELANGIECTATIC ROSACEA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
RECRUITINGYiwu, Zhejiang, 322000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.